WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS
-
After The Fire: What The 2026 Wildfires And El Niño Could Mean For U.S. Lakes And Reservoirs In 2027
In July, smoke from Canadian wildfires spread across the upper Midwest and Northeast. Now a strengthening El Niño is set to influence the coming winter. Both events matter to lake and reservoir managers because their effects on water quality will continue to emerge long after the skies clear or the El Niño passes.
-
Minneapolis Flexes Its Mussels For Source Water Monitoring Solution
Protecting municipal drinking water requires rapid visibility into changing surface source conditions. Discover how combining biological indicators with continuous inline spectrometry delivers real-time contamination alerts, preventing costly treatment plant shutdowns and safeguarding consumer health.
-
DEXSORB® Treatment At Groundwater Pump Station
Discover how upgrading existing filter infrastructure with advanced adsorbent media provided over 600 days of continuous PFAS removal, treating millions of gallons of contaminated groundwater to achieve strict drinking water compliance.
-
DEXSORB® Treatment Of Surface Water For Gravity System
Discover how a dual-vessel lead-lag media system achieved continuous non-detect levels for target legacy contaminants, treating over 250,000 gallons of surface water to support regulatory compliance and municipal drinking water goals.
-
Pretreatment Systems Enable Complete And More Economical PFAS Solutions For operators looking to optimize their PFAS removal systems, controlling the presence of dissolved organic carbon (DOC) offers an approach to minimizing operational costs due to granular activated carbon (GAC) reactivation and ion exchange media change-out.
-
What Utilities Don't Know About GAC Reuse For PFAS For utilities building PFAS treatment systems, thermal reactivation of spent granular activated carbon (GAC) may sound like the obvious answer. However, service provider availability and location, specific media acceptance criteria including quantity thresholds, restrictions on GAC type and condition, and regulatory uncertainty can all determine whether reuse is a viable option.
-
PFAS Funding Is Flowing — But Does The Water Sector Have Enough People To Deliver It? For several years, the PFAS conversation has centered on treatment options, testing, and funding. Those factors still matter, but they are no longer the primary constraint. Most utilities already understand the treatment routes available to them; the real challenge now is moving from technical possibility to operational performance, and that depends entirely on people.
-
The Cost Of Waiting: Utilities Face A Narrowing PFAS Compliance Window For years, the water industry's PFAS conversation centered on monitoring, testing, and regulatory anticipation. Today, that phase is largely over.
-
D.C. Circuit Upholds EPA's Hazardous Substance Designation For PFOA, PFOS
The U.S. Court of Appeals for the D.C. Circuit recently rejected industry challenges to the EPA's designation of PFOA and PFOS as hazardous substances under CERCLA, leaving the agency's April 2024 rule fully intact. While the case centered on the EPA's authority to make the designation, its practical significance for water utilities is simpler: the liability concerns that have accompanied the rule since its adoption remain unresolved.
-
How Donner Summit PUD Cut Backwash Water Use By 45% With Ultrasonic Algae Control
Recurring algal blooms severely compromise water treatment efficiency, clogging filters and wasting finished water through frequent backwashing. Targeted ultrasonic suppression controls raw water algae growth at the source, significantly improving influent turbidity and lowering operational costs.
VIEWS ON THE LATEST REGS
-
For years, the water industry's PFAS conversation centered on monitoring, testing, and regulatory anticipation. Today, that phase is largely over.
-
The U.S. EPA is testing a new procedural strategy to remove four PFAS drinking‑water limits from ongoing litigation, asking the D.C. Circuit Court of Appeals to invalidate those limits on the grounds that the EPA itself committed a procedural misstep when issuing the 2024 PFAS rule.
-
Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
-
In this Q&A, Dr. Elke Süss of Metrohm addresses the urgent need for haloacetic acid testing in response to “one of the most significant updates to EU drinking water monitoring in recent years.”
-
With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
MORE WATER INDUSTRY FEATURES
-
Widespread industry retirements and staffing shortages threaten operational continuity. Adopting low-maintenance, self-calibrating monitoring technology reduces reliance on specialized manual upkeep while establishing automated digital historical records that protect critical operational knowledge through workforce transitions.
-
Learn how scanners used for high resolution metrology measurements should be designed and tested for flatness of motion, particularly for atomic force microscopy (AFM).
-
PFAS rules are shifting fast. Learn how utilities can futureproof treatment strategies with flexible designs, smart staging, and emerging technologies — avoiding stranded assets and staying ahead of tomorrow’s regulations.
-
Legacy oilfield contamination requires advanced strategies to protect vital groundwater. Explore the technical challenges of subsurface remediation and how advanced oxidation processes provide a more effective pathway for destroying persistent hydrocarbons and restoring aquifer quality.
-
See how Medford, Massachusetts, used years of AMI experience to prioritize reliability, improve leak detection, enhance billing accuracy, and guide future infrastructure decisions.
-
Filter fouling has limited exosome therapeutic scalability—until now. Explore how a breakthrough reagent achieves 50% particle recovery versus 5% traditionally, enabling affordable clinical manufacturing.
-
Enhance medical device reprocessing with multi-stage filtration that reduces bacteria and contaminants, limits recontamination risk, protects device integrity, and supports safer infection control.
-
Advanced side stream filtration protects sensitive cooling infrastructure in data centers, extending membrane life, reducing water and energy use, and preventing costly downtime caused by particulate-loaded cooling water.
-
Like a referee in a contest, advanced analytical methods are essential to mediate the push and pull of different factors influencing therapeutic efficacy.
-
AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.
-
An optimized in vitro transcription (IVT) platform enables scalable, high-yield, and cost-efficient mRNA therapeutic production by leveraging data-driven process optimization and enzyme innovation to overcome key manufacturing challenges.
-
Explore a validated LC-MS/MS method for precise Semaglutide quantification in plasma, which features enhanced sensitivity, peak definition, and reproducibility using innovative technologies.
-
Thermal reactivation of granular activated carbon is a proven and scalable method to achieve >99.9% destruction removal efficiency for PFAS. This process fully restores the carbon for reuse, providing a sustainable solution that breaks the cycle of "forever chemicals."
-
High refolding yields aren’t enough. Learn how analytical characterization, structural equivalence testing, and optimized fermentation reduce scale-up risk and improve quality.
-
Explore how embedding inclusion early in clinical development enhances enrollment, strengthens data integrity, and improves outcomes, especially in oncology and rare disease trials.
-
Explore how rapid equipment replacement and peristaltic pump technology prevented regulatory violations at a major sanitation district. Learn how high-stakes infrastructure failures were resolved through strategic engineering support to ensure continuous delivery of safe water.
-
This case study demonstrates the effectiveness of a new technology for removing PFAS from well water to below the EPA’s detection limits.
-
Hear from patients and caregivers across various therapeutic areas as they offer tips on improving the clinical trial experience.